Evergreen Theragnostics
Chatham, US · Founded 2019 · Delaware corporation · 1 known investors
Founders & leadership
GB
Gerard BerNamed on SEC filing
SL
Serge LyashchenkoNamed on SEC filing
VP
Victor PaulusNamed on SEC filing
JC
James CookNamed on SEC filing
Board
ED
Investors · 1
Reported raises · per SEC filings
Form D private placements$34.9M disclosed across 2 rounds · 2020–2022
▶$15.5MraisedAug 2023 · 58 investors · PharmaceuticalsRule 506(b)
▶$15.5MraisedAug 2023 · 58 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Serge LyashchenkoDirector
- Sharon RodedDirector
- Enrico De MariaDirector
- Gerard BerDirector
- James CookExecutive Officer, Director
- Offering amount
- $15.5M
- Amount sold
- $15.5M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$19.5MraisedJun 2020 · 76 investors · PharmaceuticalsRule 506(b)
▶$19.5MraisedJun 2020 · 76 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gerard BerDirector
- Serge LyashchenkoDirector
- Enrico De MariaDirector
- Victor PaulusDirector
- James CookExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $19.5M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Evergreen Theragnostics's investors?
- Evergreen Theragnostics's investors include LIFTT.
- How much funding has Evergreen Theragnostics raised?
- Evergreen Theragnostics has disclosed $34.9M raised across 2 rounds.
- Where is Evergreen Theragnostics headquartered?
- Evergreen Theragnostics is headquartered in Chatham, US.